New Enterprise Associates 16, L.P.

Entity
Company
Business address
1954 Greenspring Drive, Suite 600, 21093 Timonium, MD
Phone
410-842-4000
State of incorporation
DE
Fiscal year end
December 31
13D/G Schedule signature
New Enterprise Associates 16, L.P. - Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Insider ownership signature
/s/ Zachary Bambach, attorney-in-fact
All SEC filings
View on sec.gov
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
New Enterprise Associates 16, L.P. has filed 68 SEC EDGAR filings since 1/17/2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D/A Open Document Open Filing Nov 17, 2025
4 Open Document Open Filing 4 Oct 6, 2025 Oct 2, 2025 001-40537
SCHEDULE 13D/A Open Document Open Filing Aug 18, 2025
SCHEDULE 13D/A Open Document Open Filing Aug 11, 2025
SCHEDULE 13D/A Open Document | Data Open Filing May 16, 2025
SCHEDULE 13D/A Open Document | Data Open Filing Mar 20, 2025
4 Open Document Open Filing 4 Dec 23, 2024 Dec 23, 2024 001-37939
SCHEDULE 13D/A Open Document | Data Open Filing Dec 23, 2024
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A( Nov 8, 2024
4 Open Document Open Filing 4 Oct 3, 2024 Oct 1, 2024 001-40537
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A( May 21, 2024
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A May 17, 2024
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL May 13, 2024
4 Open Document Open Filing 4 Apr 10, 2024 Apr 8, 2024 001-40537
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D Dec 29, 2023
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D Jun 23, 2023
4 Open Document Open Filing FORM 4 SUBMISSION Jun 15, 2023 Jun 13, 2023 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Dec 2, 2022 Nov 30, 2022 001-39343
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / AKOUOS -- SCHEDULE 13D/A(#1) Oct 28, 2022
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / ALLAKOS INC. -- SCHEDULE 13D Oct 11, 2022
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / GENOCEA BIOSCIENCES -- SCHEDULE 13D/A5E May 27, 2022
4 Open Document Open Filing FORM 4 SUBMISSION May 26, 2022 May 24, 2022 001-36289
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A3 Apr 25, 2022
4 Open Document Open Filing FORM 4 SUBMISSION Apr 13, 2022 Apr 11, 2022 001-38886
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / METACRINE -- SCHEDULE 13D/A1E Jan 5, 2022
4 Open Document Open Filing FORM 4 SUBMISSION Dec 27, 2021 Dec 10, 2021 001-39512
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A2 Nov 2, 2021
4 Open Document Open Filing FORM 4 SUBMISSION Oct 19, 2021 Oct 18, 2021 001-38886
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / GENOCEA BIOSCIENCES -- SCHEDULE 13D/A4 Apr 14, 2021
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. (MARKER THERAPEUTICS) - SCHEDULE 13DA1 Mar 26, 2021
4 Open Document Open Filing FORM 4 SUBMISSION Mar 18, 2021 Mar 16, 2021 001-37939
4 Open Document Open Filing FORM 4 SUBMISSION Mar 16, 2021 Mar 9, 2021 001-35670
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. (ALLAKOS) - SCHEDULE 13DA1E Mar 11, 2021
4 Open Document Open Filing FORM 4 SUBMISSION Dec 7, 2020 Dec 4, 2020 001-35670
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / METACRINE -- SCHEDULE 13D Sep 28, 2020
4 Open Document Open Filing FORM 4 SUBMISSION Sep 22, 2020 Sep 18, 2020 001-39512
3 Open Document Open Filing FORM 3 SUBMISSION Sep 15, 2020 Sep 15, 2020 001-39512
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / GENOCEA BIOSCIENCES -- SCHEDULE 13D/A3 Aug 3, 2020
4 Open Document Open Filing FORM 4 SUBMISSION Jul 28, 2020 Jul 24, 2020 001-36289
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. / AKOUOS -- SCHEDULE 13D Jul 7, 2020
4 Open Document Open Filing FORM 4 SUBMISSION Jul 1, 2020 Jun 30, 2020 001-39343
3 Open Document Open Filing FORM 3 SUBMISSION Jun 25, 2020 Jun 25, 2020 001-39343
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. -- SCHEDULE 13DA1 Apr 16, 2020
4 Open Document Open Filing FORM 4 SUBMISSION Apr 13, 2020 Apr 3, 2020 001-38886
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL Feb 13, 2020
3 Open Document Open Filing FORM 3 SUBMISSION Jan 29, 2020 Jan 29, 2020 001-39200
4 Open Document Open Filing FORM 4 SUBMISSION Dec 26, 2019 Dec 24, 2019 001-35670
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - MIRUM PHARMACEUTICALS, INC. 13D Jul 30, 2019
4 Open Document Open Filing FORM 4 SUBMISSION Jul 24, 2019 Jul 22, 2019 001-38981
3 Open Document Open Filing FORM 3 SUBMISSION Jul 17, 2019 Jul 17, 2019 001-38981
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - GENOCEA BIOSCIENCES 13D/A (#2) Jun 28, 2019
4 Open Document Open Filing FORM 4 SUBMISSION Jun 25, 2019 Jun 24, 2019 001-36289
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1 May 28, 2019
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - TREVI THERAPEUTICS, INC. 13D May 20, 2019
4 Open Document Open Filing FORM 4 SUBMISSION May 13, 2019 May 9, 2019 001-38886
4 Open Document Open Filing FORM 4 SUBMISSION May 9, 2019 May 7, 2019 001-35670
3 Open Document Open Filing FORM 3 SUBMISSION May 7, 2019 May 7, 2019 001-38886
SC 13D/A Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - GENOCEA BIOSCIENCES 13D/A (#1) Feb 22, 2019
4 Open Document Open Filing FORM 4 SUBMISSION Feb 19, 2019 Feb 14, 2019 001-36289
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - MARKER THERAPEUTICS, INC. 13D Oct 25, 2018
3 Open Document Open Filing FORM 3 SUBMISSION Oct 18, 2018 Oct 17, 2018 001-37939
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - ALLAKOS INC. 13D Jul 27, 2018
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - GENOCEA BIOSCIENCES, INC. 13D Jan 26, 2018
3 Open Document Open Filing FORM 3 SUBMISSION Jan 23, 2018 Jan 19, 2018 001-36289
SC 13D Open Document Open Filing NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D Nov 29, 2017
3 Open Document Open Filing FORM 3 SUBMISSION Nov 20, 2017 Nov 20, 2017 001-38295
3 Open Document Open Filing FORM 3 SUBMISSION Jul 31, 2017 Jul 24, 2017 001-35670
D Open Document Open Filing Jan 17, 2017 021-278594